Sleep Quality & PsA Abstract #0387 presented at #ACR22 attempted to shed light in this important quality of life determinant. 247 adult PsA patients were included in this study and their sleep quality was measured using the PSQI questionnaire. https://t.co/lLTnrh2yxG https://t.co/9ViEnEFE6c

Humira biosimilars became available in EU 10/18; and will soon be available in the USA w/ Amjevita (Amgen) available Jan 2023 & 6 others (Pfizer, BI, Samsung, Coherus, Sandoz, Biocon) after July 2023. https://t.co/LH3MpT0o9O https://t.co/VeCbcdq5Ie

Methotrexate + pegloticase increases response rates in gout Patients with refractory gout and those with high burden of tophi have only few options when it comes to uric acid lowering agents. https://t.co/8cqsAXuzIB https://t.co/OSpf5ehiCm

Best of ACR Day Two in PSA https://t.co/FXGCPaTGX6 https://t.co/WICtjVICC2

PET CT Imaging to Define Risk of Progression from PSO to PsA Dr. Peter Nash ( @drpnash) discusses Abstract 1018 at #ACR22 Convergence. https://t.co/Wk3ibuh9ip https://t.co/FcLjDMJCgr

Low-grade Proteinuria in Non Renal Lupus: Should We be Worried? Dr. Yuz Yusof ( @Yuz6Yusof) discusses Abstract 1463 presented at #ACR22 https://t.co/v5fHfwvapv https://t.co/zf2kJy23r2

Opioid use in PsA and SpA Dr. Eric Dein discusses Abstract 1012 at ACR22 Convergence https://t.co/Doxbk7qW33 https://t.co/2UX07T2JpS

CAR-T Therapies in Antiphospholipid Antibody Syndrome Dr. Putman and Dr. Konig discuss abstract 1677 at ACR22 Convergence. Abstract 1677: Chimeric Autoantigen-T Cell Receptor (CATCR)-T Cell Therapies to Selectively Target Autoreactive B Cells https://t.co/VeAgl3qz8J https://t.co/rN4ZLM5Ft8

New podcast available! Download where ever you get your podcasts and when can--rate, review and subscribe! Rheum Manpower Needs - More Programs https://t.co/xGXVFMkNra https://t.co/hcRGVMFZPE